A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing
- 10 September 2006
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 312 (15), 2726-2734
- https://doi.org/10.1016/j.yexcr.2006.05.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Evaluating Hypoxia-Inducible Factor-1α as a Cancer Therapeutic Target via Inducible RNA Interference In vivoCancer Research, 2005
- What's wrong with our cancer models?Nature Reviews Drug Discovery, 2005
- Development of a tightly regulated U6 promoter for shRNA expressionFEBS Letters, 2004
- Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-FluorouracilCancer Research, 2004
- Adenovirus Vector-Mediated Doxycycline-Inducible RNA InterferenceHuman Gene Therapy, 2004
- Inducible, reversible, and stable RNA interference in mammalian cellsProceedings of the National Academy of Sciences, 2004
- Inducible shRNA expression for application in a prostate cancer mouse modelNucleic Acids Research, 2003
- Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA InterferenceJournal of Virology, 2003
- Establishment of conditional vectors for hairpin siRNA knockdownsNucleic Acids Research, 2003
- Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vectorEMBO Reports, 2003